Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease

Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease

Item
http://www.wikidata.org/entity/Q35965337
Fibroblast growth factor 23Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizationsPredictive Factors of One-Year Mortality in a Cohort of Patients Undergoing Urgent-Start HemodialysisFolate receptor alpha, mesothelin and megakaryocyte potentiating factor as potential serum markers of chronic kidney disease.Association between circulating fibroblast growth factor 23, α-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatientsFibroblast growth factor 23: friend or foe in uremia?The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio Is a Useful Marker of Atherosclerosis in Early-Stage Chronic Kidney Disease.The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocolMineral metabolic abnormalities and mortality in dialysis patients.Associations of fibroblast growth factor 23 with parameters of phosphate metabolism in incident peritoneal dialysis patients.Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study.Hypophosphatemic rickets: unraveling the role of FGF23.Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis.The bone kidney axis.Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.Impact of hemodialysis, left ventricular mass and FGF-23 on myocardial mechanics in end-stage renal disease: a three-dimensional speckle tracking study.
P2860

Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease

Item
http://www.wikidata.org/entity/Q35965337
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease
@ast
Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease
@en
type
label
Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease
@ast
Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease
@en
prefLabel
Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease
@ast
Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease
@en
P2093
P2860
P304
P31
P356
10.1097/MNH.0B013E328351A391
P433
P478
P577
P698
P932